News

Grant Cardone Questions Value of College Degrees Amidst AI Growth

Grant Cardone Questions Value of College Degrees Amidst AI Growth

Reassessing College Degrees in Today's Economy

Grant Cardone, a prominent real estate mogul and entrepreneur, has long voiced skepticism about the traditional college education system, insisting that for many, obtaining a degree may not be worth the investment. Recently, he elaborated on his views, presenting several compelling arguments.

Skyrocketing Costs of Higher Education

"College degrees are not worth the cost," Cardone bluntly stated, drawing attention to the soaring tuition fees associated with private colleges. He highlighted that families are grappling with an astonishing $1.7 trillion in student loan debt, which can be financially crippling. As the cost of education continues to rise, many students find themselves in precarious debt situations that overshadow their potential career earnings.

Lengthy Duration of College Programs

Cardone further emphasized the lengthy period it takes to earn a degree. Alarmingly, nearly 46% of students do not complete their degrees within four years. This high dropout rate contributes to a growing population of educated individuals who remain unable to secure employment in their fields of study, leading to frustration and economic hardship.

Excessive Supply of Graduates

In addition to rising costs and dropout rates, Cardone pointed out the saturation of the job market with degree holders. Currently, approximately 48% of Americans hold an associate degree or higher, yet many find themselves unemployed. This phenomenon creates a workforce filled with overqualified individuals competing for a limited number of job opportunities.

Valuable Alternatives to College

According to Cardone, vocational training in trades offers a more promising path. Trades such as plumbing, electrical work, and carpentry not only require less time and financial investment but also boast significant job demand due to ongoing labor shortages. He labeled this as the "greatest shortage of jobs" in the labor market today, presenting an attractive alternative for individuals seeking stable careers without the burden of student debt.

Risks of Underemployment

Even among those who do graduate, Cardone expressed concern regarding underemployment. He noted that about 41% of graduates end up working in roles that do not necessitate a college degree, which raises questions about the actual return on investment for their education.

The Advent of Artificial Intelligence

Adding a layer of complexity to the future of education, Cardone discussed the evolving landscape shaped by artificial intelligence (AI). He warned that AI technology is advancing rapidly, enabling individuals to access extensive information and learning opportunities without the lengthy time invested in traditional education. AI is providing invaluable insights and research that were once only available through a formal education setup.

Changing Employer Expectations

Another point of concern raised by Cardone was shifting requirements within hiring practices across industries. Many companies, particularly in the technology sector, are moving away from strictly requiring college degrees, recognizing that skills and experience often outweigh formal education.

Breaking Down the Barriers

Throughout his discussions, Cardone has maintained a clear message: to achieve financial success, a college degree may not be necessary. He encourages individuals to explore alternative learning avenues and consider the return on investment before committing to a college experience. Cardone compared student loan debt to modern-day slavery, emphasizing how it entraps individuals financially and limits their life choices.

Record of Personal Experience

Although Cardone himself graduated with an accounting degree from McNeese State University, he asserts that given today's landscape, he would choose to forego a college education if he were starting his journey anew. His perspective resonates with those who have questioned the traditional path pushed by the educational system.

Engaging Discussion on Social Media

Cardone's controversial stance has sparked vibrant discussions online. Detractors of his viewpoint emphasize the social and experiential value of college, suggesting that the college years are vital for personal growth and socialization. In response, Cardone provocatively asked why one would invest in a college experience when alternatives like world travel could provide enriching experiences.

Voices of Authority

Cardone's opinions complement those of other influential figures in business. For instance, Tesla CEO Elon Musk has also commented on the limitations of traditional education, while entrepreneurs argue for the affordability of learning through free online resources. Cardone’s core message urges individuals to avoid accumulating debt and focus on acquiring practical skills that lead to real-world opportunities.

Frequently Asked Questions

What is Grant Cardone's stance on college degrees?

Grant Cardone believes that college degrees are not worth the financial burden for most individuals, citing high costs and debt.

What are the main reasons Cardone gives for avoiding college?

He cites sky-high tuition fees, long duration of degree programs, excessive supply of graduates, and the rise of AI as key reasons.

What alternatives to college does Cardone suggest?

Cardone advocates for vocational training in trades, which present lucrative job opportunities without needing a degree.

How does Cardone view the role of AI in education?

He sees AI as a disruptive force that allows individuals to learn and access information much faster than traditional education methods.

What has been the public's reaction to Cardone's message?

Cardone's views have sparked a debate, with some defending the value of the college experience for personal growth, while others support his perspective.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading